BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34112803)

  • 1. Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution.
    Lima LG; Ham S; Shin H; Chai EPZ; Lek ESH; Lobb RJ; Müller AF; Mathivanan S; Yeo B; Choi Y; Parker BS; Möller A
    Nat Commun; 2021 Jun; 12(1):3543. PubMed ID: 34112803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche.
    Chen C; Yao X; Xu Y; Zhang Q; Wang H; Zhao L; Wen G; Liu Y; Jing L; Sun X
    J Ethnopharmacol; 2019 Jun; 238():111878. PubMed ID: 30986521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions.
    Liu J; Wu S; Zheng X; Zheng P; Fu Y; Wu C; Lu B; Ju J; Jiang J
    Sci Rep; 2020 Sep; 10(1):14749. PubMed ID: 32901082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-derived exosomes from mice with highly metastatic breast cancer transfer increased metastatic capacity to a poorly metastatic tumor.
    Gorczynski RM; Erin N; Zhu F
    Cancer Med; 2016 Feb; 5(2):325-36. PubMed ID: 26725371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre-metastatic niche through activating β-adrenergic signaling.
    Chen H; Liu D; Guo L; Cheng X; Guo N; Shi M
    J Pathol; 2018 Jan; 244(1):49-60. PubMed ID: 28940209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments.
    Brummer G; Fang W; Smart C; Zinda B; Alissa N; Berkland C; Miller D; Cheng N
    Oncogene; 2020 Mar; 39(11):2275-2289. PubMed ID: 31827233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding.
    Roblek M; Strutzmann E; Zankl C; Adage T; Heikenwalder M; Atlic A; Weis R; Kungl A; Borsig L
    Neoplasia; 2016 Jan; 18(1):49-59. PubMed ID: 26806351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Experimental Models of Breast Cancer Exosome Secretion, Characterization and Function.
    Pelissier Vatter FA; Lucotti S; Zhang H
    J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):305-317. PubMed ID: 33351162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone.
    Lu X; Kang Y
    J Biol Chem; 2009 Oct; 284(42):29087-96. PubMed ID: 19720836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Biodistribution and Immune Suppressive Effects of Breast Cancer-Derived Exosomes.
    Wen SW; Sceneay J; Lima LG; Wong CS; Becker M; Krumeich S; Lobb RJ; Castillo V; Wong KN; Ellis S; Parker BS; Möller A
    Cancer Res; 2016 Dec; 76(23):6816-6827. PubMed ID: 27760789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer-Derived Exosomes Alter Macrophage Polarization
    Ham S; Lima LG; Chai EPZ; Muller A; Lobb RJ; Krumeich S; Wen SW; Wiegmans AP; Möller A
    Front Immunol; 2018; 9():871. PubMed ID: 29867925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
    Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
    J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted remodeling of breast cancer and immune cell homing niches by exosomal integrins.
    Myint PK; Park EJ; Gaowa A; Kawamoto E; Shimaoka M
    Diagn Pathol; 2020 Apr; 15(1):38. PubMed ID: 32305065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory role of epithelial cell-derived exosomes in allergic airway inflammation.
    Kulshreshtha A; Ahmad T; Agrawal A; Ghosh B
    J Allergy Clin Immunol; 2013 Apr; 131(4):1194-203, 1203.e1-14. PubMed ID: 23414598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.
    Lavender N; Yang J; Chen SC; Sai J; Johnson CA; Owens P; Ayers GD; Richmond A
    BMC Cancer; 2017 Jan; 17(1):88. PubMed ID: 28143493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes Derived From Septic Mouse Serum Modulate Immune Responses via Exosome-Associated Cytokines.
    Gao K; Jin J; Huang C; Li J; Luo H; Li L; Huang Y; Jiang Y
    Front Immunol; 2019; 10():1560. PubMed ID: 31354717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-mediated therapeutic resistance in breast cancer.
    Tan C; Hu W; He Y; Zhang Y; Zhang G; Xu Y; Tang J
    Cytokine; 2018 Aug; 108():151-159. PubMed ID: 29609137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
    Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
    J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
    Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
    Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.